阿法依泊汀注射液说明书

《阿法依泊汀注射液说明书》由会员分享，可在线阅读，更多相关《阿法依泊汀注射液说明书（6页珍藏版）》请在装配图网上搜索。

1、阿法依泊汀注射液|PROCRIT(Epoetin alfa )【中文品名】阿法依泊汀【药效类别】抗贫血药【通用药名】EPOETIN ALFA【别 名】EPO, Epoade, Epogen, Eprex, Erypo, Erythropoietin, Espo, Globuren, KRN-5702 E, Procrit【化学名称】1-165-Erythropoietin (human clone Iambda HEPOFL 13 protein moiety), glycoform a【CA登t己号】113427-24-0【结构式】【分子式】CHNOPS【分子量】【收录药典】【开发单位】Am

2、gen【首次上市】1989年，美国【性状】【用途】一种重组促红细胞生成素，用于依赖透析的慢性肾衰相关的贫血。还用于癌症病人由于化疗引起的贫血。(促红细胞生成素-a epoetin epo ,利血宝，怡泼津)本品是一种刺激红细胞生成的糖蛋白。它是应用dna重组技术及细胞培养技术而制成的人类红细胞生成素-a ,与内源性红细胞生成素有相同的生物活性。【药理作用】红细胞生成素在红细胞系发育的其后各阶段的作用，包括对原始红细胞刺激增加合成血红 蛋白，当激素处于高浓度时，加速网织红细胞由骨髓向循环释放。内源性红细胞生成素主要由肾脏产生，慢性肾衰病人红细胞生成素的产生受到抑制因而不 足，是这类病人贫血的原发

3、因素。红细胞生成素对包括需要透析和不需要经常透析的慢性 肾衰贫血病人可刺激红细胞生成。【药代动力学】慢性肾衰病人静脉给药循环半衰期大约为 413h。肝脏是主要的消除途径，肾脏是消除的 次要途径。【适应症】慢性肾衰伴有贫血的病人（包括透析和不透析的病人），也用于多发性骨髓瘤相关的贫血和 骨髓增生异常及癌症引起的贫血。【用法与用量】开始剂量：3000u,静注，每周3次，然后根据病情逐渐减少至维持量 1500u,静注，每周 23次：最高维持剂量不得超过 3000u/次，每周3次。【不良反应】不良反应：偶可发生血压升高，心悸、高血压性脑病、头痛、头晕、发热、关节痛、肌肉 痛、恶心、呕吐、腹泻、got及

4、gpt升高、瘙痒、皮疹、过敏性休克。【注意事项】用药期间应定期检查血红蛋白浓度与红细胞比容值(血红蛋白浓度不超过12g/dl或红细胞比容值36犯上)。密切观察血压变化情况，防止高血压性脑病发生，使用本品应注意补充铁质。本品应慎用于心肌梗塞、肺梗塞、脑梗塞、高血压、孕妇、儿童或有过敏倾向的病人。【制剂、规格及参考单价】注射液：1500U/瓶，3000U/瓶，EPOGENEpoetin alfa) is used to treat a lower than normal number of red bloo d cells (anemia) caused by chronic kidney fai

5、lure in patients on dialysis. EPO 2 . . GEN stimulates the bone marrow to make more red blood cells and lessens the need for red blood cell transfusions. Having more red blood cells raises the he moglobin level.EPOGEMhould not be used for treatment of anemia in place of emergency treat ment (red blo

6、od cell transfusions).mportant Safety Information?.Using EPOGENcan lead to death or other serious side effects.All patients, including patients with cancer or chronic kidney failure:You may get serious heart problems such as heart attack, stroke, heart failure, and may die sooner if you are treated

7、with EPOGEN ? to a hemoglobin level ab ove 12 g/dL. Serious health problems may happen even if you take EPOGEN? and d o not have an increase in your hemoglobin level. Your doctor should monitor yo ur hemoglobin regularly.You may get blood clots at any time while taking EPOGEN ?. If you are going to

8、have surgery, talk to your healthcare provider about whether you will need a b ood thinner to lessen the chance of blood clots during or following surgery.Call your healthcare provider or get medical help right away if you have sympt oms of blood clots such as chest pain; trouble breathing or shortn

9、ess of breat h; pain or swelling in your legs; arm or leg feels cool or appears pale; sudde n confusion or trouble with speech; sudden numbness or weakness in your face, arm, or leg; sudden trouble seeing; sudden dizziness or trouble with walking o r balance; loss of consciousness (fainting); your h

10、emodialysis vascular access stops working.Patients with cancer:Your healthcare provider has received special training through the ESA APPRISE Oncology Program in order to prescribe EPOGEN?. Before you can begin to receive EPOGEN you must sign the ESA APPRISE Oncology Patient and Healthcare Prof essi

11、onal (HCP) Acknowledgement Form to document that your healthcare provider discussed the risks of EPOGEN ? with you. When you sign this form, you are stat ng that you are aware of the risks associated with use of EPOGEN?.f you have breast, non-small cell lung, head and neck, lymphoid, or cervicalcanc

12、er, your tumor may grow faster and you may die sooner when EPOGEN ? is used experimentally to try to raise your hemoglobin beyond the amount needed to avoid red blood cell transfusion, or if you are taking EPOGEN? and not getting strong doses of chemotherapy. It is not known whether these risks exis

13、t when EP ?OGENs given according to the FDA-approved directions for use.Your healthcare provider should prescribe the smallest dose of EPOGEN? to lower the chance of getting red blood cell transfusionsAfter you have finished your chemotherapy course, EPOGEN ? treatment should be stoppedYou should no

14、t take EPOGEN ? if you:Have cancer and have not been counseled by your healthcare provider regarding the risks of EPOGEN ? and signed the ESA APPRISE Oncology Program Patient and H ealthcare Professional (HCP) Acknowledgement Form before you begin to receive ?EPOGENHave high blood pressure that is n

15、ot controlled (uncontrolled hypertension).Have been told by your healthcare provider that you?have or have ever had a ty pe of anemia called Pure Red Cell Aplasia (PRCA) that starts after treatment w th EPOGEN! or other erythropoietin medicines.Have allergies to any of the ingredients in EPOGEN ?.Do

16、 not give EPOGEN? from multidose vials to premature babies.Other side effects, which may also be serious, include:High blood pressure in patients with chronic kidney failure.Your blood pressure may go up or be difficult to control with blood pressure medicine while ta_._-.?.king EPOGEN. This can hap

17、pen even if you have never had high blood pressure b efore. Your healthcare provider should check your blood pressure often.Seizures. Seizures have occurred in patients taking EPOGEN?. If you have a seizure, get medical help right away.Antibodies to EPOGEN ?. Your body may make antibodies to EPOGEN

18、? that can block or lessen your body s ability to make red blood cells and cause you to have s evere anemia. Call your healthcare provider if you have signs of anemia such a s unusual tiredness, lack of energy, dizziness, or fainting.Serious allergic reactions. Serious allergic reactions can cause a

19、 rash over y our whole body, shortness of breath, dizziness, and fainting because of a drop in blood pressure, swelling around your mouth or eyes, fast pulse, or sweatin g. If you have such a reaction, stop using EPOGEN ? and get medical help right away.Dangers of giving EPOGEN ? to premature babies

20、. EPOGENfrom multi-dose vials co ntains benzyl alcohol and should not be given to premature babies because it c an cause death and brain damage.While you are on EPOGEN ?, tell your healthcare provider if you are, or are pla nning to, become pregnant or breast-feed.Common side effectsof EPOGEN ? in p

21、atients with chronic kidney failure include:high blood pressure, headache, joint pain, nausea, rash, swelling in legs andarms, and injection site reaction, including irritation and pain.These are not all of the possible side effects of EPOGEN?. Tell your healthcare provider about any side effects that bother you or that do not go away.